BTA 0.00% 57.0¢ biota holdings limited

research data sankyo tjw, page-2

  1. TJW
    716 Posts.
    DMA

    Actually, if would not have cost GSK much to move Relenza to the hovione device and would have overcame the difficult usage problem.
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.